Targets for Gene Therapy of Parkinson's Disease: Growth Factors, Signal Transduction, and Promoters
Open Access
- 31 March 1997
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 144 (1), 74-81
- https://doi.org/10.1006/exnr.1996.6391
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine LesionsJournal of Neurochemistry, 1994
- Trophic actions of transforming growth factor α on mesencephalic dopaminergic neurons developing in cultureNeuroscience, 1993
- Gene Transfer into Mammalian Central Nervous System Using Herpes Virus Vectors: Extended Expression of Bacterial lacZ in Neurons Using the Neuron-Specific Enolase PromoterHuman Gene Therapy, 1992
- Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.Proceedings of the National Academy of Sciences, 1992
- Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomesExperimental Neurology, 1992
- EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell cultureJournal of Neuroscience Research, 1991
- A new motor test sensitive to aging and dopaminergic functionJournal of Neuroscience Methods, 1991
- Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slowAnnals of Neurology, 1991
- MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF)Brain Research, 1990
- Nerve Cell Loss with Aging in the PutamenEuropean Neurology, 1978